Enovix (NASDAQ:ENVX – Get Free Report) had its price target dropped by investment analysts at B. Riley from $18.00 to $16.00 in a report released on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. B. Riley’s price objective would indicate a potential upside of 145.78% from the stock’s previous close. […]
Amkor Technology, Inc. (NASDAQ:AMKR – Free Report) – Equities researchers at B. Riley increased their Q2 2024 earnings per share (EPS) estimates for shares of Amkor Technology in a note issued to investors on Monday, April 29th. B. Riley analyst C. Ellis now anticipates that the semiconductor company will earn $0.22 per share for the […]
American Public Education (NASDAQ:APEI – Get Free Report) had its target price boosted by equities researchers at B. Riley from $15.00 to $16.00 in a report released on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. B. Riley’s price objective would suggest a potential upside of 15.77% from the stock’s […]
Onsemi (NASDAQ:ON – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at B. Riley in a research report issued to clients and investors on Tuesday, Benzinga reports. They currently have a $103.00 target price on the semiconductor company’s stock, down from their previous target price of $115.00. B. Riley’s price […]
Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) – Equities research analysts at B. Riley issued their Q1 2024 earnings per share (EPS) estimates for shares of Ovid Therapeutics in a research note issued to investors on Monday, April 29th. B. Riley analyst K. Patel expects that the company will earn ($0.26) per share for the […]